Jeff Yass’s iRadimed IRMD Stock Holding History

Jeff Yass’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27,981	Closed	-$2.55M	–	13947
2026 Q1	$2.69M	Buy	27,981 +6,986	+33%	+$699K	﹤0.01%	5500
2025 Q4	$2.04M	Buy	20,995 +18,145	+637%	+$1.56M	﹤0.01%	5622
2025 Q3	$203K	Sell	2,850 -10,921	-79%	-$728K	﹤0.01%	10962
2025 Q2	$823K	Buy	13,771 +4,093	+42%	+$224K	﹤0.01%	7945
2025 Q1	$508K	Buy	9,678 +5,375	+125%	+$302K	﹤0.01%	8873
2024 Q4	$237K	Buy	+4,303	New	+$226K	﹤0.01%	10343
2024 Q1	–	Sell	-8,148	Closed	-$387K	–	12724
2023 Q4	$387K	Sell	8,148 -4,970	-38%	-$209K	﹤0.01%	9265
2023 Q3	$582K	Sell	13,118 -185	-1%	-$8.6K	﹤0.01%	7875
2023 Q2	$635K	Buy	13,303 +6,819	+105%	+$308K	﹤0.01%	7750
2023 Q1	$255K	Buy	+6,484	New	+$236K	﹤0.01%	10077

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jeff Yass's IRMD Position: Q2 2026 in Review

Jeff Yass sold out of iRadimed (IRMD) in Q2 2026, closing a stake of 27,981 shares — an estimated $2.55M sold.

Jeff Yass first reported a position in IRMD in Q1 2023 and held it in 10 quarters. The position peaked at $2.69M in Q1 2026. 212 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Jeff Yass reported no remaining iRadimed position as of Q2 2026 after selling out during the quarter.
Jeff Yass sold 27,981 iRadimed shares in Q2 2026, an estimated $2.55M.
Jeff Yass first reported a position in iRadimed in Q1 2023 and held it in 10 quarters.
Jeff Yass's iRadimed position peaked at $2.69M in Q1 2026.
212 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.